You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,688,071


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,688,071 protect, and when does it expire?

Patent 10,688,071 protects FABIOR and is included in one NDA.

This patent has twenty-four patent family members in eighteen countries.

Summary for Patent: 10,688,071
Title:Topical foam composition
Abstract: The present invention relates to a novel oil in water emulsion aerosol foam composition containing an active agent for the treatment of various chronic and acute skin conditions, particularly acne and psoriasis; and processes for preparing the emulsion aerosol foam compositions. In particular, the present invention relates to oil in water emulsion aerosol foam compositions containing a retinoid in the oil phase.
Inventor(s): Loupenok; Leon (Rowville, AU)
Assignee: MAYNE PHARMA LLC (Greenville, NC)
Application Number:13/553,036
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,688,071: A Detailed Analysis

Introduction to Patent 10,688,071

United States Patent 10,688,071, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To analyze this patent, it is crucial to delve into its various components and understand the broader patent landscape.

Patent Basics and the USPTO

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. Patents are granted for inventions that meet specific criteria, including novelty, non-obviousness, and utility[2].

Patent Scope and Claims

Independent and Dependent Claims

Patent scope is often measured by the language and structure of its claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. The length and count of independent claims can be metrics for measuring patent scope, as they indicate the breadth and complexity of the invention[3].

Claim Language and Eligibility

The 2024 USPTO guidance update on AI patents emphasizes the importance of claim language in determining patent eligibility. Claims must integrate judicial exceptions (such as abstract ideas or natural phenomena) into practical applications to be considered patent-eligible. For example, a claim that merely uses a mathematical model to manipulate data without a practical application would be ineligible, whereas a claim that applies the data to improve a specific technology or solve a real-world problem would be eligible[1].

Analyzing the Claims of Patent 10,688,071

Claim Structure

To analyze the claims of Patent 10,688,071, one must examine both the independent and dependent claims. Independent claims set the foundation for what the invention encompasses, while dependent claims add specific details that further define the invention.

Practical Applications

Each claim must be evaluated to determine if it integrates abstract ideas into practical applications. For instance, if a claim involves routine data processing without any inventive concept or practical application, it would likely be rejected. However, if the claim specifies the use of the invention in a real-world application that provides tangible benefits, it would be more likely to be considered patent-eligible[1].

Subject Matter Eligibility

Subject matter eligibility is a critical aspect of patent law. Claims must not be directed to judicial exceptions such as abstract ideas, laws of nature, or natural phenomena unless they are integrated into a practical application. The 2024 USPTO guidance provides examples where claims that specify the use of an invention in a practical application, such as improving the accuracy of voice commands in a hands-free environment, are considered patent-eligible[1].

Patent Landscape and Prior Art

Searching Prior Art

To understand the patent landscape surrounding Patent 10,688,071, it is essential to conduct a thorough search of prior art. The USPTO provides several tools for this purpose, including the Patent Public Search tool, Global Dossier, and access to international patent databases. These resources help in identifying existing patents and published patent applications that may be relevant to the invention[4].

International Patent Offices

The global patent landscape is also crucial. Searching databases from international intellectual property offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can provide insights into whether similar inventions have been patented abroad[4].

Implications for Innovators and Patent Practitioners

Drafting Claims

The 2024 USPTO guidance update provides valuable insights for drafting claims that are more likely to avoid section 101 rejections. Practitioners should focus on crafting claims that integrate judicial exceptions into practical applications, demonstrating clear technological improvements and tangible benefits[1].

AI-Assisted Inventions

The update also clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution. This ensures that the use of AI as a tool does not exclude inventions from eligibility[1].

Real-World Applications and Benefits

Case Studies and Examples

Real-world applications of the claimed method or system can significantly bolster the argument for patent eligibility. For example, if the invention improves noise reduction in audio processing or enhances the accuracy of real-time speech recognition, these practical applications can demonstrate the invention's value and eligibility[1].

Key Takeaways

  • Claim Language: The language of the claims is crucial in determining patent eligibility. Claims must integrate judicial exceptions into practical applications.
  • Practical Applications: Highlighting real-world applications of the invention is essential for demonstrating patent eligibility.
  • Prior Art Search: Conducting a thorough search of prior art, both domestically and internationally, is vital for understanding the patent landscape.
  • AI-Assisted Inventions: AI-assisted inventions are evaluated based on the claimed invention itself, not the method of development.
  • Subject Matter Eligibility: Claims must meet the criteria for subject matter eligibility by integrating abstract ideas into practical applications.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The update refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing examples and detailed eligibility analysis to help practitioners draft more effective claims.

How do practical applications impact patent eligibility?

Practical applications are crucial for transforming abstract ideas into patent-eligible subject matter. They demonstrate how the invention provides concrete benefits or solves specific problems in the relevant field.

Can AI-assisted inventions be patented?

Yes, AI-assisted inventions can be patented if they meet the criteria for patent eligibility. The focus remains on the claimed invention itself, not the method of development using AI.

What tools are available for searching prior art?

The USPTO offers several tools, including the Patent Public Search tool, Global Dossier, and access to international patent databases, to help in searching prior art.

How do dependent claims affect the scope of a patent?

Dependent claims narrow down the scope of the invention by adding additional limitations to the independent claims, thereby defining the invention more specifically.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,688,071

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma FABIOR tazarotene AEROSOL, FOAM;TOPICAL 202428-001 May 11, 2012 RX Yes Yes 10,688,071 ⤷  Subscribe Y TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OF AGE OR OLDER ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.